Relationship between endothelial function and fibrinolysis in early hypertension.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  HYPERTENSION

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.HYP.31.1.321PMID 9453323
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?

  1997cited by this paper
• Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.

  1997cited by this paper
• Improved endothelial function with angiotensin-converting enzyme inhibitors.

  1997cited by this paper
• Endothelial dysfunction: clinical implications.

  1997cited by this paper
• Endothelium in hemostasis and thrombosis.

  1997cited by this paper
• Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.

  1997cited by this paper
• Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease.

  1997cited by this paper
• The renin-angiotensin system and fibrinolysis.

  1997cited by this paper
• Increased levels of tissue plasminogen activator antigen in essential hypertension. A population‐based study in Sweden

  1997cited by this paper
• New insights into the pathogenesis and prevention of acute coronary syndromes.

  1997cited by this paper
• Impaired fibrinolysis and insulin resistance in patients with hypertension.

  1996cited by this paper
• Prospective studies on left ventricular geometric patterns and exercise tolerance in unmedicated men with borderline and mild hypertension

  1996cited by this paper
• Inhibitors of fibrinolysis are elevated in atherosclerotic plaque.

  1996cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.

  1995cited by this paper
• Close relation of endothelial function in the human coronary and peripheral circulations.

  1995cited by this paper
• Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

  1994cited by this paper
• Augmentation of the synthesis of plasminogen activator inhibitor type-1 by precursors of insulin. A potential risk factor for vascular disease.

  1994cited by this paper
• Prospective study of endogenous tissue plasminogen activator and risk of stroke.

  1994cited by this paper
• Effect of captopril and enalapril on endothelial function in hypertensive patients.

  1994cited by this paper
• Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.

  1994cited by this paper
• Role of nitric oxide in reactive hyperemia in human forearm vessels.

  1994cited by this paper
• Ischemia, hyperemia, exercise, and nitric oxide. Complex physiology and complex molecular adaptations.

  1994cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993cited by this paper
• Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension.

  1993cited by this paper
• The role of endothelium in cardiovascular homeostasis and diseases.

  1993cited by this paper
• Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

  1992cited by this paper
• Sleep Disturbances in Hypertension: A Double‐Blind Study Between Isradipine and Metoprolol

  1991cited by this paper
• Platelet Function and Fibrinolytic Activity in Hypertension: Differential Effects of Calcium Antagonists and β‐Adrenergic Receptor Blockers

  1991cited by this paper
• Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

  1991cited by this paper
• Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease

  1990cited by this paper
• Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells.

  1989cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method

  1977cited by this paper

• Vascular function: a key player in hypertension

  2023cites this paper
• Biomarkers of Coronary Microvascular Dysfunction in Patients With Microvascular Angina: A Narrative Review

  2021cites this paper
• Exploration biologique de la fonction endothéliale

  2020cites this paper
• Regulatory Effects of O-GlcNAcylation in Vascular Smooth Muscle Cells on Diabetic Vasculopathy

  2020cites this paper
• Association of adipokines and endothelial dysfunction with ambulatory, central, and peripheral blood pressures in healthy young adults

  2020cites this paper
• Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise

  2019cites this paper
• Acute exercise-induced changes in hemostatic and fibrinolytic properties: analogies, similarities, and differences between normotensive subjects and patients with essential hypertension

  2019cites this paper
• Variations of perioperative baroreflex sensitivity in hypertensive and normotensive patients

  2017cites this paper
• low-Mediated Vasodilation nd the Risk of Developing ypertension in Healthy Postmenopausal Women

  2016cites this paper
• Pharmacological modulation of fibrinolytic response — In vivo and in vitro studies

  2015cites this paper
• Biological correlates of blood pressure variability in elderly at high risk of cardiovascular disease.

  2015cites this paper
• ET-1 System Activity, Cardiovascular Disease Risk Factors and Pharmacologic Intervention

  2015cites this paper
• Pleiotropic effects of antihypertensive drugs

  2015cites this paper
• Relationship of coagulation and fibrinolytic variables with arterial structure and function in Africans.

  2014cites this paper
• [Assessment of endothelial function in autoimmune diseases].

  2014cites this paper
• Évaluation de la fonction endothéliale au cours des maladies auto-immunes

  2014cites this paper
• Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease.

  2012cites this paper
• Efecto del raloxifeno en la función endotelial y la hemostasia en mujeres con enfermedad coronaria

  2011influential citation
• [Effects of raloxifene on endothelial function and hemostasis in women with ischemic heart disease].

  2011cites this paper
• Mechanism and Clinical Significance of the Prothrombotic State in Patients With Essential Hypertension

  2010cites this paper
• The role of renin-angiotensin system in prothrombotic state in essential hypertension.

  2010cites this paper
• Endothelial function & genetic polymorphisms in cerebral small vessel disease: a study investigating the relationship between endothelial function, genetic polymorphisms and cerebral small vessel disease.

  2010cites this paper
• Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage : the role of coagulation and fibrinolysis

  2009cites this paper
• Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patients

  2009cites this paper
• Function of dynamically stimulated endothelium and renin–angiotensin–aldosterone system in normotensive subjects with a family history of hypertension

  2008cites this paper
• Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.

  2008cites this paper
• Impact of the therapy by renin–angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension

  2008cites this paper
• Elevated plasma plasminogen activator inhibitor type-1 is an independent predictor of coronary microvascular dysfunction in hypertension.

  2007cites this paper
• Efectividad del Nebivolol vs Enalapril en el tratamiento de la disfunción endotelial en pacientes diabéticos tipo 2

  2007cites this paper
• Dihydropyridine Calcium Antagonists Increase Fibrinolytic Activity: A Systematic Review

  2007cites this paper
• Chapter 21 – Platelet and Coagulation Abnormalities

  2007cites this paper
• The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients.

  2007cites this paper
• Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.

  2006cites this paper
• Clinical methods for the evaluation of endothelial function – a focus on resistance arteries

  2006cites this paper
• Fibrinolysis and cardiovascular risk factors: association with fibrinogen, lipids, and monocyte count.

  2006cites this paper
• Benazepril Combined with Either Amlodipine or Hydrochlorothiazide Is More Effective than Monotherapy for Blood Pressure Control and Prevention of End-organ Injury in Hypertensive Dahl Rats

  2006cites this paper
• Target organ damage in hypertension: pathophysiology and implications for drug therapy.

  2006cites this paper
• Antihypertensive drugs and fibrinolytic function.

  2006cites this paper
• Antihypertensive Drugs and Fibrinolytic Function: Impact of Dual Calcium Channel and Renin-Angiotensin System Blockade

  2006cites this paper
• Effects of Cilnidipine on Fibrinolysis in Chinese Hypertensive Patients

  2005cites this paper
• Is the Effect of Antihypertensive Drugs on Platelet Aggregability and Fibrinolysis Clinically Relevant?

  2005cites this paper
• Biochemical risk markers: a novel area for better prediction of renal risk?

  2005cites this paper
• Is hypertension a prothrombotic state?

  2005cites this paper
• Anti-beta2-Glycoprotein I Antibody and Hypertension in Cerebral Ischemia

  2004cites this paper
• Endothelial dysfunction: methods of assessment and application to hypertension.

  2004cites this paper
• Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries.

  2004cites this paper
• The C677T polymorphism of the methylenetetrahydrofolate reductase gene is associated with the level of decrease on diastolic blood pressure in essential hypertension patients treated by angiotensin-converting enzyme inhibitor.

  2004cites this paper
• Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women.

  2004cites this paper
• Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.

  2004cites this paper
• C-reactive protein and albuminuria: independent risk markers of renal and cardiovascular disease

  2004cites this paper
• Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure.

  2004cites this paper
• HIV, Cocaine, and the Heart: Pathophysiology and Clinical Implications

  2004cites this paper
• The prothrombotic state in hypertension and the effects of antihypertensive treatment.

  2003cites this paper
• The Influence of One‐Year Treatment by Angiotensin Converting Enzyme Inhibitor on Baroreflex Sensitivity and Flow‐Mediated Vasodilation of the Brachial Artery in Essential Hypertension—Comparison with Calcium Channel Blockers

  2003cites this paper
• Relationships between fibrinogen, plasminogen activator inhibitor-1, and their gene polymorphisms in current smokers with essential hypertension.

  2003cites this paper
• The effects of antihypertensive therapy on haemostatic parameters.

  2003cites this paper
• [Metabolic effects of angiotensin-II receptor blockers].

  2002cites this paper
• Hemostasis Imbalance in Experimental Hypertension

  2002cites this paper
• Platelet function and fibrinolytic activity in borderline and mild hypertension. The influence of age, exercise, smoking and antihypertensive therapy.

  2002cites this paper
• Increased Expression of Protease-Activated Receptor-2 (PAR2) and PAR4 in Human Coronary Artery by Inflammatory Stimuli Unveils Endothelium-Dependent Relaxations to PAR2 and PAR4 Agonists

  2001cites this paper
• Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

  2001cites this paper
• Effects of four angiotensin II-receptor antagonists on fibrinolysis in postmenopausal women with hypertension

  2001cites this paper
• Close relationship of tissue plasminogen activator-plasminogen activator inhibitor-1 complex with multiple organ dysfunction syndrome investigated by means of the artificial pancreas

  2001cites this paper
• Long-term use of angiotensin-converting enzyme inhibitors to modify endothelial dysfunction: a review of clinical investigations.

  2000cites this paper
• Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy?

  2000cites this paper
• Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension.

  2000cites this paper
• Endothelial dysfunction in arterial hypertension

  2000cites this paper
• Protease-activated receptors: sentries for inflammation?

  2000cites this paper
• Clinical Implications of Elevated PAI-1 Revisited: Multiple Arterial Thrombosis in a Patient with Essential Thrombocythemia and Elevated Plasminogen Activator Inhibitor-1 (PAI-1) Levels with a Review of the Literature

  1999cites this paper
• Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.

  1999cites this paper
• Protease-Activated Receptor-2 Activation Evidence for Selective Effects of Chronic Hypertension on Cerebral Artery Vasodilatation

  1999cites this paper
• Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature.

  1999cites this paper
• Endothelial dysfunction in human disease.

  1999cites this paper
• The effects of angiotensin-converting enzyme inhibition on endothelial dysfunction: potential role in myocardial ischemia.

  1998cites this paper